Yamazaki H - Search Results

1

Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.

Shimada T, Tanaka K, Takenaka S, Murayama N, Martin MV, Foroozesh MK, Yamazaki H, Guengerich FP, Komori M. Shimada T, et al. Among authors: yamazaki h. Chem Res Toxicol. 2010 Dec 20;23(12):1921-35. doi: 10.1021/tx100286d. Chem Res Toxicol. 2010. PMID: 21053930 Free PMC article.

2

Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T. Yamazaki H, et al. Protein Expr Purif. 2002 Apr;24(3):329-37. doi: 10.1006/prep.2001.1578. Protein Expr Purif. 2002. PMID: 11922748

3

[P450 and carcinogenesis].

Yamazaki H, Kamataki T. Yamazaki H, et al. Nihon Yakurigaku Zasshi. 2002 Apr;119(4):208-12. doi: 10.1254/fpj.119.208. Nihon Yakurigaku Zasshi. 2002. PMID: 11979725 Review. Japanese.

4

Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

Kiyotani K, Yamazaki H, Fujieda M, Iwano S, Matsumura K, Satarug S, Ujjin P, Shimada T, Guengerich FP, Parkinson A, Honda G, Nakagawa K, Ishizaki T, Kamataki T. Kiyotani K, et al. Among authors: yamazaki h. Pharmacogenetics. 2003 Nov;13(11):689-95. doi: 10.1097/00008571-200311000-00005. Pharmacogenetics. 2003. PMID: 14583682

5

Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians.

Kiyotani K, Fujieda M, Yamazaki H, Shimada T, Guengerich FP, Parkinson A, Nakagawa K, Ishizaki T, Kamataki T. Kiyotani K, et al. Among authors: yamazaki h. Drug Metab Pharmacokinet. 2002;17(5):482-7. doi: 10.2133/dmpk.17.482. Drug Metab Pharmacokinet. 2002. PMID: 15618701 Free article.

6

Cytochrome P450 reconstitution systems.

Yamazaki H, Shimada T. Yamazaki H, et al. Methods Mol Biol. 2006;320:61-71. doi: 10.1385/1-59259-998-2:61. Methods Mol Biol. 2006. PMID: 16719374

7

Rat cytochrome P450 2C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol.

Yamazaki H, Shimizu M, Nagashima T, Minoshima M, Murayama N. Yamazaki H, et al. Drug Metab Dispos. 2006 Nov;34(11):1803-5. doi: 10.1124/dmd.106.011627. Epub 2006 Aug 8. Drug Metab Dispos. 2006. PMID: 16896062

8

Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.

Shimada T, Murayama N, Okada K, Funae Y, Yamazaki H, Guengerich FP. Shimada T, et al. Among authors: yamazaki h. Chem Res Toxicol. 2007 Mar;20(3):489-96. doi: 10.1021/tx600299p. Epub 2007 Feb 10. Chem Res Toxicol. 2007. PMID: 17291012

9

Missense and nonsense mutations of the flavin-containing monooxygenase 3 gene in a Japanese cohort.

Shimizu M, Tomioka S, Murayama N, Yamazaki H. Shimizu M, et al. Among authors: yamazaki h. Drug Metab Pharmacokinet. 2007 Feb 25;22(1):61-4. doi: 10.2133/dmpk.22.61. Drug Metab Pharmacokinet. 2007. PMID: 17329912 Free article.

10

Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.

Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H. Murayama N, et al. Among authors: yamazaki h. Biochem Pharmacol. 2007 Jun 15;73(12):2020-6. doi: 10.1016/j.bcp.2007.03.012. Epub 2007 Mar 19. Biochem Pharmacol. 2007. PMID: 17433262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,133 results

Search Page

Filters